Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127970311 | 12797031 | 1 | I | 201608 | 20160920 | 20160929 | 20160929 | EXP | FR-ABBVIE-16P-056-1741218-00 | ABBVIE | 76.17 | YR | F | Y | 0.00000 | 20160929 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127970311 | 12797031 | 1 | PS | TARKA | TRANDOLAPRILVERAPAMIL HYDROCHLORIDE | 1 | Oral | LP 180/2 MG | UNKNOWN | 20591 | 1 | DF | QD | ||||||
| 127970311 | 12797031 | 2 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | N | UNKNOWN | 0 | 40 | MG | QD | ||||||
| 127970311 | 12797031 | 3 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | UNKNOWN | 0 | 100 | MG | QD | |||||||
| 127970311 | 12797031 | 4 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | UNKNOWN | 0 | 1 | G | TID | |||||||
| 127970311 | 12797031 | 5 | SS | LEXOMIL | BROMAZEPAM | 1 | Oral | UNKNOWN | 0 | ||||||||||
| 127970311 | 12797031 | 6 | C | LASILIX | FUROSEMIDE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 127970311 | 12797031 | 7 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127970311 | 12797031 | 1 | Hypertension |
| 127970311 | 12797031 | 2 | Hypercholesterolaemia |
| 127970311 | 12797031 | 3 | Type 2 diabetes mellitus |
| 127970311 | 12797031 | 4 | Osteoarthritis |
| 127970311 | 12797031 | 5 | Anxiety |
| 127970311 | 12797031 | 6 | Hypertension |
| 127970311 | 12797031 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127970311 | 12797031 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127970311 | 12797031 | Dyspnoea | |
| 127970311 | 12797031 | Interstitial lung disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127970311 | 12797031 | 2 | 20160906 | 0 | ||
| 127970311 | 12797031 | 6 | 20160903 | 0 |